Cartesian Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Cartesian Therapeutics, Inc. (RNAC) reported Earnings Per Share, Basic and Diluted of -$0.22 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-13
- Cartesian Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.22.
- Cartesian Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.14.
- Cartesian Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.09.
- Cartesian Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.25.
- Cartesian Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.68.
- Cartesian Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.22.
- Cartesian Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$2.92.
- Cartesian Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2017 was -$3.20.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$0.22 10-Q · filed 2021-05-13 | -$0.37 derived: net income ÷ weighted average shares · filed 2022-05-05 | -$0.46 derived: net income ÷ weighted average shares · filed 2022-05-05 | -$0.70 derived: net income ÷ weighted average shares · filed 2022-05-05 |
| 2020-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$0.24 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$0.48 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$0.68 10-K · filed 2021-03-12 |
| 2020-09-30 | -$0.09 10-Q · filed 2020-11-05 | -$0.33 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$0.54 10-Q · filed 2020-11-05 | -$0.78 derived: net income ÷ weighted average shares · filed 2021-05-13 |
| 2020-06-30 | -$0.25 10-Q · filed 2020-08-06 | -$0.46 10-Q · filed 2020-08-06 | -$0.72 derived: net income ÷ weighted average shares · filed 2021-05-13 | -$0.97 derived: net income ÷ weighted average shares · filed 2021-05-13 |
| 2020-03-31 | -$0.21 10-Q · filed 2021-05-13 | -$0.47 derived: net income ÷ weighted average shares · filed 2021-05-13 | -$0.72 derived: net income ÷ weighted average shares · filed 2021-05-13 | -$1.06 derived: net income ÷ weighted average shares · filed 2021-05-13 |
| 2019-12-31 | -$0.28 10-K · filed 2020-03-12 | -$0.54 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$0.90 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$1.22 10-K · filed 2021-03-12 |
| 2019-09-30 | -$0.26 10-Q · filed 2020-11-05 | -$0.62 derived: net income ÷ weighted average shares · filed 2020-11-05 | -$0.94 10-Q · filed 2020-11-05 | -$1.45 derived: net income ÷ weighted average shares · filed 2021-03-12 |
| 2019-06-30 | -$0.37 10-Q · filed 2020-08-06 | -$0.68 10-Q · filed 2020-08-06 | -$1.22 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$1.85 derived: net income ÷ weighted average shares · filed 2021-03-12 |
| 2019-03-31 | -$0.31 10-Q · filed 2020-05-07 | -$0.88 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$1.54 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$2.33 derived: net income ÷ weighted average shares · filed 2021-03-12 |
| 2018-12-31 | -$0.65 10-K · filed 2020-03-12 | -$1.37 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$2.21 derived: net income ÷ weighted average shares · filed 2021-03-12 | -$2.92 10-K · filed 2021-03-12 |
| 2018-09-30 | -$0.71 10-K · filed 2020-03-12 | -$1.55 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$2.27 10-Q · filed 2019-11-08 | -$3.14 derived: net income ÷ weighted average shares · filed 2020-03-12 |
| 2018-06-30 | -$0.84 10-K · filed 2020-03-12 | -$1.55 10-Q · filed 2019-08-08 | -$2.43 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$3.09 derived: net income ÷ weighted average shares · filed 2020-03-12 |
| 2018-03-31 | -$0.71 10-K · filed 2020-03-12 | -$1.59 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$2.25 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$3.09 derived: net income ÷ weighted average shares · filed 2020-03-12 |
| 2017-12-31 | -$0.88 10-K · filed 2019-03-15 | -$1.54 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$2.38 derived: net income ÷ weighted average shares · filed 2020-03-12 | -$3.20 10-K · filed 2020-03-12 |
| 2017-09-30 | -$0.66 10-K · filed 2019-03-15 | -$1.50 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$2.31 10-Q · filed 2018-11-08 | -$3.08 derived: net income ÷ weighted average shares · filed 2019-03-15 |
| 2017-06-30 | -$0.85 10-K · filed 2019-03-15 | -$1.67 10-Q · filed 2018-08-08 | -$2.44 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$2.87 derived: net income ÷ weighted average shares · filed 2019-03-15 |
| 2017-03-31 | -$0.82 10-K · filed 2019-03-15 | -$1.59 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$2.02 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$3.17 derived: net income ÷ weighted average shares · filed 2019-03-15 |
| 2016-12-31 | -$0.77 10-K · filed 2018-03-15 | -$1.20 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$2.34 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$3.89 10-K · filed 2019-03-15 |
| 2016-09-30 | -$0.43 10-K · filed 2018-03-15 | -$1.57 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$3.39 10-Q · filed 2017-11-07 | -$5.57 derived: net income ÷ weighted average shares · filed 2018-03-15 |
| 2016-06-30 | -$2.75 10-K · filed 2018-03-15 | -$6.90 10-Q · filed 2017-08-11 | -$11.03 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$14.56 derived: net income ÷ weighted average shares · filed 2018-03-15 |
| 2016-03-31 | -$4.52 10-K · filed 2018-03-15 | -$8.78 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$12.28 derived: net income ÷ weighted average shares · filed 2018-03-15 | -$16.21 derived: net income ÷ weighted average shares · filed 2018-03-15 |
| 2015-12-31 | -$4.26 10-K · filed 2017-03-28 | -$7.76 derived: net income ÷ weighted average shares · filed 2017-03-28 | -$11.68 derived: net income ÷ weighted average shares · filed 2017-03-28 | -$15.13 10-K · filed 2018-03-15 |
| 2015-09-30 | -$3.50 10-K · filed 2017-03-28 | -$7.43 derived: net income ÷ weighted average shares · filed 2017-03-28 | -$10.86 10-Q · filed 2016-11-10 | |
| 2015-06-30 | -$3.93 10-K · filed 2017-03-28 | -$7.36 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | -$3.43 10-K · filed 2017-03-28 | |||
| 2014-12-31 | -$7.84 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |